Silva, JoanaAlvariño, RebecaGoettert, Márcia I.Caruncho, Hector J.Alves, Celso2022-08-232022-08-232022Silva J, Alvariño R, Goettert MI, Caruncho HJ and Alves C (2022), Editorial: Natural products as drivers in drug development for neurodegenerative disorders. Front. Pharmacol. 13:932179. doi: 10.3389/fphar.2022.9321791663-9812http://hdl.handle.net/10400.8/7583Funding : CA acknowledges the support by the Portuguese Foundation for Science and Technology (FCT) through the strategic projects (UIDB/04292/2020 and UIDP/04292/2020) granted to MARE—Marine and Environmental Sciences Centre, Associate Laboratory ARNET (LA/P/0069/2020), and CROSS-ATLANTIC (PTDC/BIA-OUT/29250/2017), co-financed by European Regional Development Fund (FEDER), through the Operational Programme for Competitiveness and Internationalization (COMPETE 2020). This work was also supported by FCT and CAPES cooperation agreement through project MArTics (FCT/DRI/CAPES 2019.00277. CBM).engNatural products (NP),NeuroinflammationOxidative stressApoptosisMechanisms of actionNeuropharmacologyDrug discoveryEthnopharmacologyjournal article10.3389/fphar.2022.932179